Skip to main content
. 2015 Oct 13;59(11):6922–6929. doi: 10.1128/AAC.01390-15

TABLE 2.

Activity of elbasvir against HCV genotype 3 repliconsa

Sequence identificationb Con1 backbone
JFH backbone
No. of replicon colonies Meanc EC90 ± SD (nM) No. of replicon colonies Meanc EC90 ± SD (nM)
Parental replicon 300 0.006 ± 0.004 TMTC 0.019 ± 0.010
GU814823 (S52) 9 0.042 ± 0.011 503 0.065 ± 0.026
GQ356207 3 0.016 ± 0.008 472 0.035 ± 0.027
AM493639 0 ND 0 ND
EU826291 21 0.005 ± 0.003 TMTC 0.096 ± 0.117
EU826299 0 ND 0 ND
GQ300882 0 ND 482 0.613 ± 0.855
GQ356215 0 ND 242 0.016
HM042077 2 0.011 ± 0.010 598 0.034 ± 0.037
HM042078 4 0.007 ± 0.006 412 0.031 ± 0.022
HQ912953 2 0.007 ± 0.004 51 0.016
AF320799 0 0.119 43 0.387 ± 0.380
NC_009824 ND 0.120 ± 0.060 ND ND
a

EC, effective (inhibitory) concentration; TMTC, too many to count; ND, not done.

b

Numbers are GenBank accession numbers. Parental replicons of con1 (genotype 1b) and JFH (genotype 2a) were used as controls.

c

Average from ≥3 independent experiments.